Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-15
DOI
10.1186/s13045-021-01032-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CLEAR: coverage-based limiting-cell experiment analysis for RNA-seq
- (2020) Logan A. Walker et al. Journal of Translational Medicine
- Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group
- (2020) Manuela A. Hoechstetter et al. LEUKEMIA
- Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm
- (2020) Annika Scheffold et al. Current Oncology Reports
- Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia
- (2020) Jennifer A. Woyach et al. Cancer Discovery
- Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
- (2020) Kate Milne et al. Current Oncology Reports
- Selinexor for advanced hematologic malignancies
- (2020) Janek S. Walker et al. LEUKEMIA & LYMPHOMA
- Recognition of nuclear export signals by CRM1 carrying the oncogenic E571K mutation
- (2020) Jordan M. Baumhardt et al. MOLECULAR BIOLOGY OF THE CELL
- Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial
- (2020) Nagesh Kalakonda et al. Lancet Haematology
- Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments
- (2019) Boyu Hu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia
- (2019) Brian Giacopelli et al. BLOOD
- Eµ-TCL1xMyc: a novel mouse model for concurrent CLL and B-cell lymphoma
- (2019) Fabienne Lucas et al. CLINICAL CANCER RESEARCH
- Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
- (2019) Kirsten Fischer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Altered nuclear export signal recognition as a driver of oncogenesis
- (2019) Justin Taylor et al. Cancer Discovery
- Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
- (2019) Daehwan Kim et al. NATURE BIOTECHNOLOGY
- Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma
- (2019) Ajai Chari et al. NEW ENGLAND JOURNAL OF MEDICINE
- BISR-RNAseq: an efficient and scalable RNAseq analysis workflow with interactive report generation
- (2019) Venkat Sundar Gadepalli et al. BMC BIOINFORMATICS
- Biology and treatment of Richter syndrome
- (2018) Davide Rossi et al. BLOOD
- Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways
- (2018) Lynne V. Abruzzo et al. HAEMATOLOGICA
- Chronic lymphocytic leukaemia
- (2018) Michael Hallek et al. LANCET
- Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways
- (2018) Lynne V. Abruzzo et al. HAEMATOLOGICA
- The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation
- (2018) Sean D. Reiff et al. Cancer Discovery
- XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy
- (2017) Vincent Camus et al. Journal of Hematology & Oncology
- Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1
- (2017) A Cosson et al. LEUKEMIA
- Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma
- (2016) Fabrice Jardin et al. AMERICAN JOURNAL OF HEMATOLOGY
- Clinical and molecular characteristics of XPO1 mutations in patients with chronic lymphocytic leukemia
- (2016) Preetesh Jain et al. AMERICAN JOURNAL OF HEMATOLOGY
- Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
- (2016) Z A Hing et al. LEUKEMIA
- DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
- (2016) Christopher C Oakes et al. NATURE GENETICS
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
- (2016) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteome-wide search for functional motifs altered in tumors: Prediction of nuclear export signals inactivated by cancer-related mutations
- (2016) Gorka Prieto et al. Scientific Reports
- Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia
- (2015) Z. A. Hing et al. BLOOD
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- Identifying Drug-Target Selectivity of Small-Molecule CRM1/XPO1 Inhibitors by CRISPR/Cas9 Genome Editing
- (2015) Jasper E. Neggers et al. CHEMISTRY & BIOLOGY
- Nuclear transport factors: global regulation of mitosis
- (2015) Douglass J Forbes et al. CURRENT OPINION IN CELL BIOLOGY
- MiXCR: software for comprehensive adaptive immunity profiling
- (2015) Dmitriy A Bolotin et al. NATURE METHODS
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia
- (2015) James S. Blachly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning
- (2015) Koray Kırlı et al. eLife
- Near-infrared photoactivatable control of Ca2+ signaling and optogenetic immunomodulation
- (2015) Lian He et al. eLife
- RNA Export through the NPC in Eukaryotes
- (2015) Masumi Okamura et al. Genes
- LocNES: a computational tool for locating classical NESs in CRM1 cargo proteins
- (2014) Darui Xu et al. BIOINFORMATICS
- Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting
- (2014) L.-A. Sutton et al. HAEMATOLOGICA
- Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
- (2014) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Causal analysis approaches in Ingenuity Pathway Analysis
- (2013) Andreas Krämer et al. BIOINFORMATICS
- Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)
- (2013) J. A. Woyach et al. BLOOD
- Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
- (2013) Dan A. Landau et al. CELL
- PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models
- (2013) David G. Winkler et al. CHEMISTRY & BIOLOGY
- Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276
- (2013) J Schmidt et al. LEUKEMIA
- SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients
- (2013) S Jeromin et al. LEUKEMIA
- Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
- (2012) R. Lapalombella et al. BLOOD
- Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells
- (2012) J Etchin et al. LEUKEMIA
- Sequence and structural analyses of nuclear export signals in the NESdb database
- (2012) Darui Xu et al. MOLECULAR BIOLOGY OF THE CELL
- Nuclear export of proteins and drug resistance in cancer
- (2011) Joel G. Turner et al. BIOCHEMICAL PHARMACOLOGY
- The role of phosphatidylinositol 3-kinase- in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia
- (2011) S. E. M. Herman et al. BLOOD
- The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
- (2011) D. Rossi et al. BLOOD
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- CAL-101, a p110 selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
- (2010) B. J. Lannutti et al. BLOOD
- The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
- (2010) Ulf Klein et al. CANCER CELL
- CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation
- (2010) A Efanov et al. LEUKEMIA
- The Histopathologic and Molecular Basis for the Diagnosis of Histiocytic Sarcoma and Histiocyte–Associated Lymphoma of Mice
- (2010) X. Hao et al. VETERINARY PATHOLOGY
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Structural basis for leucine-rich nuclear export signal recognition by CRM1
- (2009) Xiuhua Dong et al. NATURE
- Structural basis for assembly and disassembly of the CRM1 nuclear export complex
- (2009) Xiuhua Dong et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Crystal Structure of the Nuclear Export Receptor CRM1 in Complex with Snurportin1 and RanGTP
- (2009) T. Monecke et al. SCIENCE
- Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: Structure–activity relationship and mechanism of action
- (2008) Tine Van Neck et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Integrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
- (2008) P. Ouillette et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now